PTB Reports, Vol 9, Issue 3, Sep-Dec, 2023

PTB Reports,
Vol 9, Issue 3, Sep-Dec, 2023

Levetiracetam-Induced Urination and Urinary Frequency in Pediatrics. A Case Report

Manar Bayounis,Nouf Al-Assadi

PTB Reports,9(3):59-61
Read More

Research Article

Perceptions and Attitudes about the Voluntary/Charitable Pharmaceutical Care Services in Saudi Arabia

Yousef Ahmed Alomi,Abeer Hussin Almasoudi,Maha Hussein Almadany,Ghudair Tashan Alanazi,Khawla Ibrahim Al-shahrani

PTB Reports,9(3):62-70
Read More

Drug Review

Drug Review: Vonoprazan

Juman Alsaab

PTB Reports,9(3):71-72
Read More

Review Article

Virtual Clinical Pharmacy Services: A New Initiative Project in Saudi Arabia

Yousef Ahmed Alomi,Asma Mohammed Alzahrani,Haifa Shabeeb Almutairi,Tahani Mohammed Alotaibi,Mona Yousef Lubbad,Nouf Abdurazaq Alhaza,Raghad Maluoh Alanazi

PTB Reports,9(3):73-76
Read More

PTB Reports [Pharmacology, Toxicology and Biomedical Reports] - It is an international, peer-review, open access, online journal publishing research articles, review articles, clinical case reports and recent trends in experimental and clinical pharmacology, toxicology and Biomedicine. It covers clinical pharmacokinetics, biochemical pharmacology, clinical biochemistry, molecular biology, analytical toxicology, psychopharmacology, neuropharmacology, cardiovascular and renal pharmacology and other systemic pharmacology.

Editor-in-Chief : Dr. Rafiq Abou-Shaaban, Ph D
Subjects Covered : Pharmacology, Toxicology, and Biomedicine
ISSN : 2395 - 4736 ; Frequency : Tri-annual (3 issues/year)
Indexed and Abstracted in : Google Scholar, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
Open Access Journal: PTB Reports is an open access journal, which allows authors to fund their article to be open access from publication.